Page 19 - Pharma Sector News Today

Read more about Ciplas Gulf arm to sell 4 biosimilar medicines in Australia, New Zealand on Business Standard. Cipla Gulf will be responsible for commercialisation of patented biosimilars of the biologic medicine brands -- Aflibercept, Ustekimumab,Denosumab and Golimumab.

The power brands and their line extensions coupled with price hikes are expected to help growth prospects

Read more about Investors turn to pharma stocks amid market crash; Nifty Pharma gains 1.5% on Business Standard. Among individual stocks, Lupin zoomed 3.4 per cent in the intra-day trade and hit a high of Rs 1,060, Sun Pharmaceuticals advanced 2 per cent, and Dr Reddys Labs gained 1.7 per cent.

The government is continuously working to reduce regulatory compliance burden on the pharma industry in a bid to improve ease of doing business in the country, Union Minister for Chemicals & Fertilisers D V Sadananda Gowda said on Thursday. Addressing the inaugural session of The India Pharma 2021 & India Medical Device 2021 event here, the minister also emphasised that the domestic pharma industry has the capability to achieve the target of USD 130 billion turnover by 2030. "Under the leade...

The Union Cabinet on Wednesday approved production-linked incentive (PLI) scheme for pharmaceuticals over a period of eight years (FY21-FY29). It will benefit domestic manufacturers, help in creating employment and is expected to contribute to the availability of wider range of affordable medicines for consumers. The total quantum of incentive under the scheme is about Rs 15,000 crore. The manufacturers of pharmaceutical goods registered in India will be grouped based on their global manufac...

Centre extends PLI scheme to pharma sector, investment worth Rs15 crore expected Premium Bulk drugs or active pharmaceutical ingredients (APIs) are the active raw materials used in medicines to give them their therapeutic effect. Photo: Bloomberg 1 min read Share Via Read Full Story NEW DELHI: The Union Cabinet, chaired by Prime Minister Narendra Modi, on Wednesday, approved the Production Linked Incentive (PLI) Scheme for the domestic pharmaceutical sector for financial years 2020-21 to 2028-2...

The development comes just a week after the Cabinet approved the PLI scheme for telecom equipment.

"The idea behind the consultation is to gather insights on issues that may have a bearing on competition in the pharmaceutical market in India," the regulator said in a public notice.

Karnataka to set up 2,500 smart classrooms for digital learning in next 2 months ANI | Updated: Feb 19, 2021 03:30 IST Bengaluru (Karnataka) [India], February 19 (ANI): As part of promoting digital learning, 2,500 classrooms of higher education in the state will be converted into smart classrooms in the next two months, informed Deputy Chief Minister Dr CN Ashwatha Narayana on Thursday. Speaking after launching the newly built gym house and inaugurating the...

Read more about Pharmas 3Q profitability improvement starts to taper off: Ind-Ra on Business Standard. The ratings agency does not expect Indian pharmaceutical companies to sustain the healthy operating margins reported during 3Q FY21 and 9M FY21